Long-Term Outcomes, Quality of Life, and Kidney Safety Net for PTA Recipients
Purpose of Review Pancreas transplant alone (PTA) is an established treatment for selected patients with brittle diabetes mellitus and preserved kidney function. As perioperative outcomes have improved, attention has shifted toward long-term graft durability, quality of life, and late complications, particularly chronic kidney disease (CKD). This review summarizes contemporary evidence on long-term outcomes after PTA and examines the emerging need for a formal kidney safety net for this population. Recent Findings Recent registry analyses and single-center studies demonstrate durable pancreas graft survival and sustained improvement in glycemic control and quality of life after PTA. However, progressive renal dysfunction remains a significant late complication, even among recipients with acceptable baseline kidney function. Unlike recipients of simultaneous pancreas–kidney or pancreas-after-kidney transplantation, PTA recipients lack a defined allocation pathway or safety net when kidney failure develops. Summary Long-term success after PTA increasingly depends on kidney preservation and equitable access to kidney transplantation. Development of a kidney safety net for PTA recipients warrants renewed consideration to preserve the clinical and quality-of-life benefits of pancreas transplantation.
Authors
- Erik B. Finger (ORCID: https://orcid.org/0000-0003-3899-6985)
- Michael G. Megaly (ORCID: https://orcid.org/0009-0003-1198-6610)
Institutions
- University of Delaware (US)
Publication Details
- Journal
- Current Transplantation Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s40472-026-00540-9
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00